Serum γ-glutamyltransferase and the risk of heart failure in men and women in Finland

Heart

Volumn 99, Issue 3, 2013, Pages 163-167

  Wang, Yujie ^a,b   Tuomilehto, Jaakko ^c,d   Jousilahti, Pekka ^d   Salomaa, Veikko ^d   Li, Bin ^b   Antikainen, Riitta ^e   Mähönen, Markku ^c   Katzmarzyk, Peter T ^a   Hu, Gang ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY AGRICULTURAL CENTER   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e Oulu City Hospital   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; EDUCATION; ENZYME BLOOD LEVEL; ETHNIC GROUP; FEMALE; FINLAND; FINNISH; HEART FAILURE; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; SOCIOECONOMICS; SYSTOLIC BLOOD PRESSURE; VALVULAR HEART DISEASE;

ADULT; AGED; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; FOLLOW-UP STUDIES; FORECASTING; GAMMA-GLUTAMYLTRANSFERASE; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SEX DISTRIBUTION; TIME FACTORS;

EID: 84871754398     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302972     Document Type: Article

References (30)

1. Lloyd-Jones DAdams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the American heart association. Circulation 2010;121:e46-e215.
2. Lee DH, Silventoinen K, Hu G, et al. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J 2006;27:2170-6. (Pubitemid 44412830)
3. Fraser A, Harris R, Sattar N, et al. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake analysis of the British women's heart and health study and meta-analysis. Arterioscler Thromb Vasc Biol 2007;27:2729-35. (Pubitemid 350158929)
4. Dhingra R, Gona P, Wang TJ, et al. Serum gamma-glutamyltransferase and risk of heart failure in the community. Arterioscler Thromb Vasc Biol 2010;30:1855-60.
5. Strasak AM, Kelleher CC, Klenk J, et al. Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality - A prospective population-based study in 76 113 Austrian adults. Arterioscler Thromb Vasc Biol 2008;28:1857-65.
6. Ruttmann E, Brant LJ, Concin H, et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163 944 Austrian adults. Circulation 2005;112:2130-7. (Pubitemid 41475806)
7. Lee DH, Buijsse B, Steffen L, et al. Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart Survey. Eur J Cardiovasc Prev Rehabil 2009;16:16-20.
8. Emdin M, Passino C, Pompella A, et al. Gamma-glutamyltransferase as a cardiovascular risk factor. Eur Heart J 2006;27:2145-6. (Pubitemid 44412822)
9. Paolicchi A, Emdin M, Ghliozeni E, et al. Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation 2004;109:1440. (Pubitemid 38387833)
10. Vartiainen E, Laatikainen T, Peltonen M, et al. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 2010;39:504-18.
11. Pajak A, Kuulasmaa K, Tuomilehto J, et al. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. The WHO MONICA Project. World Health Stat Q 1988;41:115-40. (Pubitemid 19034355)
12. Hu G, Jousilahti P, Antikainen R, et al. Joint effects of physical activity, body mass index, waist circumference, and waist-to-hip ratio on the risk of heart failure. Circulation 2010;121:237-44.
13. Wang Y, Tuomilehto J, Jousilahti P, et al. Occupational, commuting, and leisure-time physical activity in relation to heart failure among Finnish men and women. J Am Coll Cardiol 2010;56:1140-8.
14. Hu G, Qiao Q, Silventoinen K, et al. Occupational, commuting, and leisure-time physical activity in relation to risk for type 2 diabetes in middle-aged Finnish men and women. Diabetologia 2003;46:322-9. (Pubitemid 36547586)
15. Mahonen M, Jula A, Harald K, et al. The validity of heart failure diagnoses obtained from administrative registers. Eur, J Prev Cardiolog 2012. http://cpr.sagepub.com/content/early/2012/02/06/2047487312438979.abstract (accessed November 5 2012).
16. Martin I, Grotewiel MS. Oxidative damage and age-related functional declines. Mech Ageing Dev 2006;127:411-23.
17. Chrysohoou C, Castorini C, Aggelopoulos P, et al. Moderate coffee consumption lowers the likelihood of developing left ventricular systolic dysfunction after an acute coronary event in normotensive, but not in hypertensive patients. J Am College Cardiol 2009;53:A221-A.
18. Ha MH, Lee DH, Jacobs DR. Association between serum concentrations of persistent organic pollutants and self-reported cardiovascular disease prevalence: results from the National Health and Nutrition Examination Survey, 1999-2002. Environ Health Perspect 2007;115:1204-9.
19. Lee DH, Lee IK, Porta M, et al. Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia 2007;50:1841-51. (Pubitemid 47222867)
20. Lee DH, Jacobs DR. Is serum gamma-glutamyltransferase an exposure marker of xenobiotics? Empirical evidence with polycylic aromatic hydrocarbon. Clin Chem Lab Med 2009;47:860-2.
21. Lee DH, Jacobs DR, Gross M, et al. gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the coronary artery risk development in young adults (CARDIA) study. Clin Chem 2003;49:1358-66. (Pubitemid 36900623)
22. Ishizaka N, Ishizaka Y, Toda EI, et al. Association between Gamma- Glutamyltransferase levels and insulin resistance according to alcohol consumption and number of cigarettes smoked. J Atheroscler Thromb 2010;17:476-85.
23. Ruttmann E, Brant LJ, Concin H, et al. gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality - An epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005;112:2130-7. (Pubitemid 41475806)
24. Yamada J, Tomiyama H, Yambe M, et al. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis 2006;189:198-205. (Pubitemid 44441282)
25. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000;18:655-73. (Pubitemid 30406736)
26. Arab L. Epidemiologic evidence on coffee and cancer. Nutr Cancer 2010;62:271-83.
27. Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007;191:235-40. (Pubitemid 46400718)
28. Lim JS, Yang JH, Chun BY, et al. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress?. Free Radic Biol Med 2004;37:1018-23.
29. Kastorini CM, Chrysohoou C, Panagiotakos D, et al. Moderate coffee consumption lowers the likelihood of developing left ventricular systolic dysfunction in post-acute coronary syndrome normotensive patients. J Med Food 2009;12:29-36.
30. Salomaa V, Havulinna A, Saarela O, et al. Thirty-one novel biomarkers as predictors for clinically incident diabetes. PLoS One 2010;5:e10100.